Editas Medicine Higher After Favorable Patent Ruling By: Benzinga via Benzinga February 16, 2017 at 13:52 PM EST Editas Medicine Inc (NASDAQ: EDIT) shares are trading higher by $2.00 (9 percent) at $26.30 in Thursday's session. The issue is ... Read More >> Related Stocks: Editas Medicine